Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent CDI”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)UnknownNCT06107569
What this trial is testing

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Who this might be right for
Clostridium Difficile Infections
Hospital Universitario Evangelico de Curitiba 24
Not applicableUnknownNCT03053505
What this trial is testing

A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Sejtterapia Kozpont Kft. 150
Early research (Phase 1)UnknownNCT02134392
What this trial is testing

Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

Who this might be right for
Clostridium Difficile
Jonathan Gisser 15
Testing effectiveness (Phase 2)Study completedNCT03829475
What this trial is testing

ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI

Who this might be right for
Inflammatory Bowel DiseasesClostridium Difficile Infection
Brigham and Women's Hospital 61
Not applicableEnded earlyNCT01372943
What this trial is testing

Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Queen's University 4
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Large-scale testing (Phase 3)Study completedNCT03244644
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

Who this might be right for
Clostridium Difficile Infection (CDI)
Rebiotix Inc. 320
Testing effectiveness (Phase 2)Study completedNCT02589847
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Rebiotix Inc. 272
Post-approval studies (Phase 4)WithdrawnNCT05077085
What this trial is testing

Bezlotoxumab Versus FMT for Multiple Recurrent CDI

Who this might be right for
Clostridium InfectionsClostridioides DifficileEnterocolitis, Pseudomembranous
Leiden University Medical Center
Post-approval studies (Phase 4)Study completedNCT03880539
What this trial is testing

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
University of Kansas Medical Center 4
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Post-approval studies (Phase 4)Ended earlyNCT04000555
What this trial is testing

Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
University of South Florida 26
Not applicableNot Yet RecruitingNCT06533800
What this trial is testing

Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection

Who this might be right for
CDI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 24
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Not applicableLooking for participantsNCT01905709
What this trial is testing

Fecal Microbiota Transplantation for C Diff Infection

Who this might be right for
Clostridium Difficile Infection
Englewood Hospital and Medical Center 100
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Large-scale testing (Phase 3)Looking for participantsNCT06237452
What this trial is testing

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection Recurrence+7 more
Vedanta Biosciences, Inc. 852
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Large-scale testing (Phase 3)Study completedNCT03183128
What this trial is testing

ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 182
Load More Results